Pencil Beam Scanning Proton Therapy for Lymphoma Patients with Mediastinal Involvement: A Dosimetric Study and Preliminary Clinical Data K. Dedeckova 1,

Slides:



Advertisements
Similar presentations
بسم الله الرحمن الرحيم ﴿و قل رب زدنى علماً﴾ صدق الله العظيم.
Advertisements

Background/Purpose ATRT is a rare and aggressive CNS tumor usually presenting in very young children (age less than 5 years). Aggressive treatments have.
Pulmonary Stereotactic Ablative Radiotherapy:
Introduction Treatment of metastatic prostate cancer with androgen deprivation therapy (ADT) is effective, but can be associated with debilitating side.
Evaluation of Femur Fracture Risk in Soft-Tissue Sarcoma of the Thigh Treated with Intensity- Modulated Radiation Therapy (IMRT) Michael R. Folkert, MD.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
Dosimetric Evaluation of Planning Techniques in Lung SBRT
TWO FIELD BREAST PLAN VS. OPTIMIZED CONFORMAL BREAST PLAN: COMPARISON OF PLAN PARAMETERS Authors: Borko Basarić, Ozren Čudić, Milan Teodorović, Borislava.
Treatment Planning Hodgkin Lymphoma.
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.
INTRODUCTION  The majority of clinical trials addressing outcomes in limited- stage small cell lung cancer (LS-SCLC) following definitive chemoradiotherapy.
Low dose chemotherapy with insulin (Insulin Potentiation Therapy) in combination with hormone therapy for treatment of castration resistant prostate cancer.
CTOS Soft Tissue Sarcoma of the Extremity Comparison of Conformal Post-operative Radiotherapy (CRT) and Intensity Modulated Radiotherapy (IMRT)
Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma Luigi Marcheselli, Raffaella Marcheselli, Alessia Bari, Eliana.
Cardiac events after treatment with high dose radiation therapy +/- chemotherapy for non-small cell lung cancer Linglong Tang, Anwen Liu, Daniel Gomez,
Definitive chemo-radiotherapy for esophageal cancer; failure pattern and salvage treatments Ryuta Koike, Y. Nishimura, K. Nakamatsu, S. Kanamori, M. Okubo,
Decreased Risk of Radiation Pneumonitis With Coincident Concurrent Use Of Angiotensin- Converting Enzyme Inhibitors In Patients Receiving Lung Stereotactic.
Involved Field Radiotherapy versus No Further Treatment in Patients with Clinical Stages IA/IIA Hodgkin Lymphoma and a “Negative” PET Scan After 3 Cycles.
Ten Year Outcomes In Men Under 60 Treated With Iodine-125 Permanent Brachytherapy As Monotherapy GU - Prostate Cancer: Novel Imaging (MRI,PET) & Brachytherapy.
Validity of more than 30Gy radiation therapy for long-surviving patients with painful bone metastases E.Katayama 1,2, H.Okada 1, I.Asakawa 2, T.Tamamoto.
Permanent Interstitial Implants Ideal strategy to curatively manage small volume gynecologic malignancies Can deliver high cumulative radiation dose to.
Hodgkin’s Lymphoma in Young Female Patients Can be Safely Treated with Radiation: A New Technique That Avoids The Breasts And Decrease The Heart Dose.
Corresponding author Name; 2015 North Jefferson St; Three-Year Analysis of Urinary Toxicity in Two Prospective Trials.
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl,
بسم الله الرحمن الرحيم. Adult Hodgkin’s Lymphoma in the Eastern Part of Libya Dr. M.Mangoush, R. Nafo, S.Kardah, M.Letaiwish, S.Kardah, F.Bodabous, S.Ebkhatra.
Stereotactic Ablative Body Radiotherapy for Non small cell lung cancer
Conflict of Interest Declaration: Nothing to Disclose Presenter: Sophie Lamoureux Title of Presentation: A Comparison of Stereotactic Body Radiotherapy.
Purpose and Objectives: To investigate
Outcomes of Stereotactic Ablative Radiotherapy (SABR) for a Second Primary Lung Cancer (SPLC): Evidence in Support of Routine CT Surveillance C. J.A. Haasbeek,
Tumor Location Correlates with Radiation Pneumonitis after Stereotactic Body Radiation Therapy (SBRT) for Primary and Oligometastatic Lesions of the Lung.
Palliative Single 8 Gy Radiotherapy for Symptomatic Aggressive Lymphomas 2666 A -408 Oguchi M, Eba J, Tanaka O, Kozuka T, Murofushi K, Toshiyasu T, Tsurugai.
Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.
Reducing excess imaging dose to cancer patients receiving radiotherapy Adam Schwertner, Justin Guan, Xiaofei Ying, Darrin Pelland, Ann Morris, Ryan Flynn.
第三讲: Basic treatment planning - Dengsong Zhu, MS, DABR Medical Physicist Radiation Safety Officer.
Department of Clinical Radiotherapy, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK R4 한재준 1.
PHASE II TRIAL OF HYPOFRACTIONATED BREAST IRRADIATION WITH VMAT-SIB TECHNIQUE: TOXICITY AND EARLY CLINICAL ASSESSMENT IN 270 PATIENTS F. De Rose¹, F. Alongi¹,
Image Guided Interstitial Brachytherapy For Locally Advanced Gynaecological Cancer With A MUPIT Applicator M.A.D. Haverkort, MD 1, E. Van der Steen - Banasik,
Proton Therapy Patterns-of-Care and Early Outcomes for Hodgkin Lymphoma: Results from the Proton Collaborative Group Registry Bradford Hoppe MD, MPH William.
Results of Definitive Radiotherapy in Anal Canal Carcinoma
The use of 4DCT images to optimize the Internal Target Volume in Radiotherapy  Nikos Giakoumakis, Brian Winey, Joseph Killoran, Tania Lingos, Laurence.
Director Department of Pediatric Hematology & Oncology Delhi, INDIA.
Introduction Materials & Methods Results Conclusion
Evaluation Of RTOG Guidelines For Monte Carlo Based Lung SBRT Planning
Response to chemotherapy
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
VMAT-technique (volumetric modulated arc therapy), IMRT-technique (intensity modulated radiotherapy) and 3D-conformal radiation for Lymphomas in Radiation.
Insert tables Insert figure
Modern Treatment Planning
Median Volume (cc) of GTV Receiving Dose
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
Insert tables Insert graphs Insert figure
Radiation Oncology Department, Bank of Cyprus Oncology Center.
L. A. den Otter. , R. M. Anakotta. , M. Dieters. , C. T. Muijs. , S
CK RS for non-resectable pancreatic tumors
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
Re-irradiation with VMAT for progressive brain metastases after previous whole brain radiation for radionecrosis risk avoidance. Marilena Theodorou, MD.
Clinical Radiation Oncology NMT232 L 10
Neoadjuvant Adjuvant Curative Palliative
Technical Advances of Radiation Therapy for Thymic Malignancies
Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?  Georgios Ntentas, DPhil, Katerina Dedeckova, MD, Michal.
Rarer Bone Tumors Thomas F. DeLaney, M.D. Co-Director: Sarcoma Program
Proton Therapy for Thymic Malignancies: Multi-institutional Patterns-of-Care and Early Clinical Outcomes from the Proton Collaborative Group Registry &
Bradford Hoppe MD, MPH William Hartsell, MD
Proton Beam Therapy for Liver Cancer is Well Tolerated: Outcomes from the Proton Collaborative Group REG Trial Michael Chuong, M.D.1,2, Smith Apisarnthanarx,
Results: Purpose/Objectives: Methods: Conclusions:
Machine learning analysis for predicting survival in stage III non-small cell lung cancer patients receiving definitive chemotherapy and proton radiation.
Average Dose-Volume Ratio
Presentation transcript:

Pencil Beam Scanning Proton Therapy for Lymphoma Patients with Mediastinal Involvement: A Dosimetric Study and Preliminary Clinical Data K. Dedeckova 1, H. Mocikova 2, J. Markova 2, L. Gaherova 2, J. Koren 3, B. Vackova 3, V. Vondracek 1, D. Sindelar 1, T. Kohlova 1, B. Ondrova 1, I. Kantorova 4, P. Vitek 1, R. Pytlik 3, J. Kubes 1. 1 Proton Therapy Department, Proton Therapy Center Czech, Prague, Czech Republic, 2 Internal Hematology Clinic, Faculty Hospital Kralovske Vinohrady and 3 rd Faculty of Medicine, Charles University in Prague, Czech Republic, 3 1 st Medical Department – Clinical Department of Haematooncology, 1 st Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Czech Republic, 4 Nuclear Medicine Department, Proton Therapy Center Czech, Prague, Czech Republic Proton radiotherapy (PRT)= technique with potential to decrease risk of acute and late toxicity. From dosimetric point of view, PRT seems to be optimal RT technique for most lymphoma patients. Pencil beam scanning (PBS) is a new PRT technique. There is a lack of data for mediastinal lymphoma irradiated via PBS. The aim of this study is to confirm dosimetric advantages of PBS compared to standard RT technique for lymphoma patients (pts) and to evaluate acute toxicity and early control. Proton radiotherapy using PBS technique offers promising and safe possibility for most pts indicated for mediastinal RT. PBS has a potential to decrease significantly the dose to important organs at risk compared to standard photon technique. Early local control of PBS PRT is comparable to standard photon techniques. INTRODUCTION METHODS Table 1. Characteristics of patients (n=30) CharacteristicsNumber of patients Gender: males/females13/17 Histology: Hodgkin lymphoma25 DLBCL3 T lymphoblastic NHL1 Peripheral T NHL1 Evaluable pts (males/females) 18(9/9) Age: median (range), years32.5(13-65) RT volume: Involved field8 Residual disease9 Involved site1 Overall 30 pts with supradiaphragmatic lymphoma were irradiated using PBS between 5/ /2015. The analysis was done for all patients with mediastinal RT more than 3 months after RT (18 pts). PBS was used in the first-line treatment in 15 pts and 3 pts were reirradiated. Target volume definitions in early stages: involved field RT (05/ /2015) and involved site RT (from 03/2015). Residual disease was irradiated in advanced stages of lymphoma. Characteristics of pts is summarized in Table 1. Organ motion management: ITV definition according 4D-CT (5/ /2015), deep inspiration breath hold technique- DIBH (from 4/2015). The range of total doses (PTV98%): CGE (median 30 CGE). Comparative 3D-conformal photon plan (standard in CZ) was made for all evaluable pts. Dosimetric advantages of PBS over 3D-conformal photon RT are presented in Table 2. and Table 3. Table 2. Dosimetric advantages of PBS over 3D-conformal photon RT Organs at risk (assessed parameter) Photons (dose Gy) Protons (dose Gy) Absolute difference (dose Gy) Relative difference (%) Lungs bilat. (Dmean)10,275,924,3458 Lung sin. (Dmean)12,126,885,2457 Lung dx. (Dmean)9,335,353,9857 Spinal cord (Dmax in 2% of volume)27,6110,6616,9539 Mamma sin. ( Dmean)2,962,030,9269 Mamma dx. (Dmean)1,800,561,2331 Ventricle sin. (Dmean)8,363,574,7843 Ventricle dx.( Dmean)11,436,824,6260 Atrium sin. ( Dmean)20,5112,947,5763 Atrium dx. (Dmean)16,4910,146,3462 Valve mitr. (Dmean)17,777,1810,5940 Valve tric. (Dmean)13,716,257,4646 Valve aort. (Dmean)23,3410,9312,4147 Body (Dmean)3,611,312,2936 Esophagus (Dmean)23,0619,213,8583 Table 3. Dosimetric advantages of PBS over 3D-conformal photon RT (dose-volume param.) Organs at riskPhotonsProtons Absolute difference Relative difference Lungs bilat. V5Gy 43%30%13%69% Lung sin. V5Gy 51%34%17%67% Lung dx. V5Gy 39%27%12%70% Mamma sin.V4Gy 15%13%2%91% Mamma dx.V4Gy 10%4%6%38% Body V4Gy 16%8% 50% RESULTS Dose to organs at risk (OAR): the dose to most OAR was significantly lower compared to standard photon technique. Relevant sparing of lungs, spinal cord, cardiac structures, volume of body exposed to radiation was reached. The sparing of mammary glands (evaluable 9 pts) and esophagus was individual. Treatment response: 16 pts complete remission, 1 pt disseminated tumor out of RT field (4 months after RT), 1 pt died from generalized CMV infection 5 months after RT (RT was done after allo-SCT). Acute RT toxicity: mild, in most pts: dysphagia gr.I, radiodermatitis gr.I/II, asymptomatic neutropenia gr.II in 2 pt and gr.III in 2 pts. Asymptomatic transient postRT changes of lungs occurred on postRT CT scan in 2 pts. CONCLUSIONS